Strategic use of statistical thinking in drug development

Area of Science:

• Pharmaceutical industry
• Drug development
• Biostatistics

Background:

• The role of statisticians in the pharmaceutical industry has significantly evolved over the past 40-50 years.
• Regulatory developments and advancements in drug development science have been key drivers of this evolution.
• Increased regulatory requirements for statistical input have broadened the scope of statistical applications.

Purpose of the Study:

• To examine the evolving role of statisticians in the pharmaceutical industry.
• To assess the preparedness of the statistical profession for emerging opportunities in drug discovery and development.
• To highlight the need for changes in attitude, training, and experience for statisticians.

Main Methods:

• Qualitative analysis of industry trends and regulatory landscapes.
• Review of the historical progression of statistical applications in pharmaceutical research.
• Assessment of the current state of statistical training and professional development.

Main Results:

• Statisticians are increasingly involved in strategic decision-making within the pharmaceutical business.
• The scope of statistical applications has widened due to regulatory demands and scientific progress.
• There is a potential gap in the preparedness of statisticians regarding attitude and training for these expanded roles.

Conclusions:

• The statistical profession must adapt its approach and enhance training to optimize its contribution to drug discovery and development.
• Proactive engagement with strategic issues is crucial for statisticians to influence business direction.
• Continuous professional development is essential for statisticians to meet the evolving demands of the pharmaceutical industry.